Efficacy of pemetrexed in a patient with brain metastases during crizotinib treatment.

Zhang, Jie; Wu, Qiong-Ya; Li, Xue-Fei; Qi, Hui-Wei; Wu, Feng-Ying; Zhou, Cai-Cun

Zhang, Jie; Wu, Qiong-Ya; Li, Xue-Fei; Qi, Hui-Wei; Wu, Feng-Ying; Zhou, Cai-Cun.

Afiliação

Zhang J; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
Wu QY; Department of Medical Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
Li XF; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
Qi HW; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
Wu FY; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
Zhou CC; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.

Per Med ; 12(6): 549-553, 2015 Nov.

Article em En | MEDLINE | ID: mdl-29750613

Palavras-chave

ALK positive; brain metastases; crizotinib; non-small-cell lung cancer; pemetrexed

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Per Med Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google